Alzheimer's drug prescribed off-label could accelerate cognitive decline for some patients

Donepezil, a medication that is approved to treat people with Alzheimer’s disease, should not be prescribed for people with mild cognitive impairment without a genetic test.

from Dementia Big http://ift.tt/2ljnnUO via alcoholic dementia

http://ift.tt/2lG1vEa